Leishmaniasis remains a major public health burden due to limited vaccines, toxic treatments, and drug resistance. The M32 metallocarboxypeptidase of Leishmania donovani (LdMCP1) represents a promising target due to its presence in trypanosomatids and absence ... ...

请注册登录后继续浏览